La información proviene del Ranking Iberoamericano
SIR 2010, Scimago Institutions Ranking donde informa que nuestra Universidad, aparece con un bajo número de artículos publicados, pero con un
magnifico indicador de la calidad de las revistas donde se publican los artículos.
Debemos hacer un esfuerzo para mejorar los indicadores de la UDES y es misión de todos publicar en Revistas de alta calidad académica.
PUBLICACIONES INCLUIDAS EN EL ANALISIS (2003-2010)
1. Lopez-Jaramillo P. Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. Journal of Hypertension 2008; 26: 1886-188
2. Lopez-Jaramillo P, Arenas WD, Garcia RG, Rincon MY, Lopez M. The role of the L-arginine- nitric oxide pathway in preeclampsia. Therapeutic Advances in Cardiovascular Disease. 2008; 2: 261-275
3. Garcia RG, Lopez-Jaramillo P. Cardiovascular prevention in high-risk patients with type 2 diabetes mellitus: when to start it? European Hearth Journal 2008; 29:2058-2059
4. Lopez-Jaramillo P, Garcia G, Camacho P.A, Herrera E, Castillo V. Interrelationship between body mass index, C-reactive protein and blood pressure in a Hispanic pediatric population. American Journal of Hypertension 2008; 21: 527-532.
5. López-Jaramillo P , Silva S.Y, Rodríguez Salamanca N, Duran A, Mosquera W, Castillo V. Are Nutrition-Induced Epigenetic Changes the Link Between Socioeconomic Pathology and Cardiovascular Diseases? American Journal of Therapeutics 15, 2008; 15:362-372.
6. López-Jaramillo P, Herrera J.A, Arenas-Mantilla M, Jáuregui I.E, Mendoza M.A. Subclinical Infection as a Cause of Inflammation in Preeclampsia. American Journal of Therapeutics 15 2008;15: 373-376.
7. Lopez-Jaramillo P, Pradilla LP, Castillo V, Lahera V. Socioeconomical pathology as determinant of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension. Revista Española de Cardiología. 2007; 60: 168-178.
8. Silva SY , Rueda LC , Márquez GA , López M , Smith DJ , Calderón CA , Castillo JC , Matute J , Rueda-Clausen CF , Orduz A , Silva FA , Kampeerapappun P , Bhide M , López-Jaramillo P . Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON. Trials. 2007; 8: 26.
9. Herrera JA, Parra B, Herrera E, Botero JE, Arce RM, Contreras A, Lopez-Jaramillo P. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. Journal of Hypertension 2007; 25: 1459-1464.
10. López-Jaramillo P, Pradilla LP, Lahera V, Silva F, Rueda-Clausen C, Marquez G. A randomized, double blind, cross-over, placebo-controlled clinical trial to assesss the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglycemia and abdominal obesity. ARAMIA. Trials 7: 28, 2006.
11. Silva S, Rueda LC, Lopez M, Velez ID, Rueda-Clausen CF, Smith DJ, Muñoz G, Mosquera H, Silva FA, Buitrago A, Diaz H , Lopez- Jaramillo P . Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis (NCT00317629). Trials 7:14, 2006.
